Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Needle-free jet injection for measles-rubella vaccination
jRCTs031220030Completed
- Sponsor
- BIKEN CO.,Ltd.
- Start
- Jun 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of Measles rubella vaccine in measles and rubella, sponsored by BIKEN CO.,Ltd. Primary endpoints: Immunogenicity: measles and rubella antibody titers at 6–8 weeks, Immunogenicity: measles and rubella antibody titers at 1 year and 3 more. Started Jun 2022; status: completed.
02
Drugs
Measles rubella vaccine
03
Conditions
measlesrubella
Beyond the preview
Go deeper on jRCTs031220030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220030.